Treg Cell Therapy for Autoimmune Diseases from Germany
Treg cell therapy for autoimmune diseases consists of regulatory T-cells expanded ex vivo from patient blood and modified for enhanced suppressive function, used to treat graft-versus-host disease. This product is a cell therapy product under tariff item 3002.51.00, as it involves modified cell cultures for therapeutic use.
Duty Rate — Germany → Canada
0%
Import Tips
• Confirm that the product is classified as a cell therapy product and not as an immunological product under heading 30.02
• Provide evidence of the ex vivo expansion and modification to CBSA
• Ensure compliance with Health Canada's regulations for cell therapies